ICU SeaStar Medical Holding Corp
Financings ·
Holders exercised older warrants at a reduced $3.866 per share and received new warrants. H.C. Wainwright & Co., LLC acted as exclusive placement agent, and the offering closed on October 5, 2026.
We have not published a story on SeaStar Medical Holding yet. When there is news, it will appear here.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $1.2 million | $135,000 |
| Research and development | $7.5 million | $9.1 million |
| Net income (loss) | -$12.2 million | -$24.8 million |
| Cash from operations | -$13.6 million | -$16.0 million |
| Cash and equivalents | $1.8 million |
Our latest story on this, dated Oct 5, 2026: "SeaStar Medical collects about $3.3 million from warrant exercises". The story links the filing or release it is based on. Read the story.
SeaStar Medical Holding Corp trades under the ticker ICU on NASDAQ.
SeaStar Medical Holding Corp is listed on NASDAQ.
Our directory records SeaStar Medical Holding Corp under United States.
aibio.space lists SeaStar Medical Holding Corp among 2,820 public biotech companies and publishes its news here as stories appear.
$1.2 million for the fiscal year ended Dec 31, 2025, as reported to the SEC.
SeaStar Medical Holding Corp reported a net loss of $12.2 million for the fiscal year ended Dec 31, 2025, and used $13.6 million of cash in operations, per its annual report to the SEC.
$7.5 million in the fiscal year ended Dec 31, 2025, per its annual report.
$6.3 million in cash at Jun 30, 2025, per its 10-Q.
Our latest story on SeaStar Medical Holding, dated Oct 5, 2026: "SeaStar Medical collects about $3.3 million from warrant exercises". Holders exercised older warrants at a reduced $3.866 per share and received new warrants. H.C. Wainwright & Co., LLC acted as exclusive placement agent, and the offering closed on October 5, 2026. Source.
Press Follow on this page to add SeaStar Medical Holding to your Following list, or subscribe to the aibio.space newsletter. We have published 1 story naming SeaStar Medical Holding so far, in Financings.
Reported a shareholder vote on a reverse stock split or more authorized shares. SEC Form 8-K (Items 5.02,5.07,9.01). Source
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio